Niranjan Sardesai, Chief Operating Officer at INOVIO PHARMACEUTICALS, INC. (INO), bought 4,000 shares at $5.50 ($22K) on 2015-09-30, disclosed to the SEC on 2015-09-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| INO | BUY | 2013-03-22 | $13K | — | Filing → |
| INO | BUY | 2012-05-17 | $5K | — | Filing → |